A carregar...
Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors
Allogeneic hematopoietic stem cell transplantation (HSCT) is well established as a potentially curative treatment for patients with CML. The success of imatinib and other tyrosine kinase inhibitors (TKI) as initial therapy has changed the treatment paradigm in this disease. Allogeneic hematopoietic...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3226776/ https://ncbi.nlm.nih.gov/pubmed/22035758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2011.03.028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|